Literature DB >> 6721149

The use of Cerenkov radiation for monitoring reactions performed in minute volumes: examples from recombinant DNA technology.

S L Berger.   

Abstract

A method in which minute volumes of initially unknown size are used to monitor reactions has been developed. It is applicable whenever 32P-labeled substrates can be distinguished from 32P-labeled products by a filter assay. Three determinations are required: the Cerenkov radiation emitted (1) by the unknown aliquots affixed to filters and dried; (2) by the identical filters after processing to remove either substrates or products; and (3) by a precisely measured, necessarily much larger, aliquot in solution. Given the value obtained in (3) and the efficiency with which Cerenkov radiation can be detected in the dry state (25%) compared with the liquid state (56%), the unknown volumes, together with their acid-insoluble radioactivity, can be calculated from (1) and (2), respectively. Since the known volume counted in solution is not lost to further manipulations, the entire procedure uses less than 0.5 microliter.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6721149     DOI: 10.1016/0003-2697(84)90254-9

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  3 in total

Review 1.  The next generation of positron emission tomography radiopharmaceuticals in oncology.

Authors:  Samuel L Rice; Celeste A Roney; Pierre Daumar; Jason S Lewis
Journal:  Semin Nucl Med       Date:  2011-07       Impact factor: 4.446

2.  Cerenkov luminescence imaging of medical isotopes.

Authors:  Alessandro Ruggiero; Jason P Holland; Jason S Lewis; Jan Grimm
Journal:  J Nucl Med       Date:  2010-06-16       Impact factor: 10.057

3.  Evaluation of 89Zr-rituximab tracer by Cerenkov luminescence imaging and correlation with PET in a humanized transgenic mouse model to image NHL.

Authors:  Arutselvan Natarajan; Frezghi Habte; Hongguang Liu; Ataya Sathirachinda; Xiang Hu; Zhen Cheng; Claude M Nagamine; Sanjiv Sam Gambhir
Journal:  Mol Imaging Biol       Date:  2013-08       Impact factor: 3.488

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.